Medicare Enrolled
Dr. Saakshi Khattri, MD
Student in an Organized Health Care Education/Training Program · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khattri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khattri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khattri
Dr. Saakshi Khattri is a student in an organized health care education/training program specialist in New York, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Khattri performed 1,102 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khattri received a total of $1,691,872 from 38 pharmaceutical and/or device companies across 1738 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khattri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 16% volume in NY
$1,691,872 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,102
Medicare services
Top 16% in NY for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $107 | $430 |
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
235 | $109 | $290 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
123 | $149 | $580 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
96 | $6 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $75 | $290 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
63 | $52 | $270 |
| Laser treatment for inflammatory skin disease, less than 250 sq cm This procedure uses a laser to treat inflammatory skin conditions covering an area smaller than 250 square centimeters. |
55 | $138 | $700 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
43 | $82 | $260 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $123 | $540 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
23 | $106 | $450 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $47 | $160 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
19 | $1 | $30 |
| New patient office visit, complex (60-74 min) | 17 | $195 | $830 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $150 | $660 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $95 | $440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,691,872
Total received (2018-2024)
Avg $241,696/year across 7 years
Top 0% in NY for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
1,738
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$653,427
2023
$437,862
2022
$370,256
2021
$163,890
2020
$46,079
2019
$20,126
2018
$232
Payments by company (2024)
ABBVIE INC.
$124,782
Janssen Biotech, Inc.
$107,539
UCB, Inc.
$94,844
Amgen Inc.
$62,823
Lilly USA, LLC
$51,843
E.R. Squibb & Sons, L.L.C.
$46,925
Regeneron Healthcare Solutions, Inc.
$43,409
Boehringer Ingelheim International GmbH
$38,079
Novartis Pharmaceuticals Corporation
$22,212
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,348
Eli Lilly and Company
$10,980
Takeda Pharmaceuticals U.S.A., Inc.
$10,565
Arcutis Biotherapeutics, Inc.
$7,135
PFIZER INC.
$6,119
UCB SA
$4,500
MAYNE PHARMA COMMERCIAL LLC
$3,480
Biogen, Inc.
$3,280
GENZYME CORPORATION
$315
Ortho Dermatologics, a division of Bausch Health US, LLC
$75
LEO Pharma Inc.
$43
Almirall LLC
$40
Galderma Laboratories, L.P.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Dermavant Sciences, Inc.
$22
Top 3 companies account for 50.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$409,285
Janssen Biotech, Inc.
$217,134
Lilly USA, LLC
$203,917
UCB, Inc.
$186,186
Janssen Scientific Affairs, LLC
$164,941
Regeneron Healthcare Solutions, Inc.
$87,745
Boehringer Ingelheim Pharmaceuticals, Inc.
$68,220
Amgen Inc.
$63,049
E.R. Squibb & Sons, L.L.C.
$53,642
Novartis Pharmaceuticals Corporation
$47,617
Boehringer Ingelheim International GmbH
$38,079
Arcutis Biotherapeutics, Inc.
$22,964
PFIZER INC.
$22,286
LEO Pharma Inc.
$19,177
Eli Lilly and Company
$16,730
GENZYME CORPORATION
$15,797
Takeda Pharmaceuticals U.S.A., Inc.
$10,565
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$9,200
NOVARTIS PHARMACEUTICALS CORPORATION
$8,188
ARGENX US, INC.
$6,889
UCB SA
$4,500
Ortho Dermatologics, a division of Bausch Health US, LLC
$3,679
MAYNE PHARMA COMMERCIAL LLC
$3,480
Biogen, Inc.
$3,280
Dermavant Sciences, Inc.
$2,197
AbbVie Inc.
$1,359
Incyte Corporation
$1,044
AbbVie, Inc.
$143
Galderma Laboratories, L.P.
$118
AstraZeneca Pharmaceuticals LP
$84
Genentech USA, Inc.
$77
SANOFI-AVENTIS U.S. LLC
$66
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
Regeneron Pharmaceuticals, Inc.
$50
Almirall LLC
$40
Sun Pharmaceutical Industries Inc.
$39
EPI Health, LLC
$27
Kyowa Kirin Co., Ltd
$13
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · Bimzelx · CIBINQO · COSENTYX · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EUCRISA · HUMIRA · Humira · ILUMYA · JUBLIA · Klisyri · LITFULO · OLUMIANT · OPZELURA · Olumiant · Otezla · RINVOQ · SAPHNELO · SILIQ · SIMPONI ARIA · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · VYVGART · Winlevi · Xolair · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
34,951
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khattri is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NY), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khattri experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khattri performed 264 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khattri receive payments from pharmaceutical companies?
Yes. Dr. Khattri received a total of $1,691,872 from 38 companies across 1,738 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khattri's costs compare to other student in an organized health care education/training programs in New York?
Dr. Khattri's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khattri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in New York
Browse student in an organized health care education/training programs in New York ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in NY
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in NY
Which NY student in an organized health care education/training programs receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology